Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Verschraegen

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Anticancer Research|January 1, 1995
Modulation of the response to chemotherapy in a human melanoma clone by the site of growth in the nude mouseC F Verschraegen, J T Mendoza, A J Kozielski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Paraneoplastic syndromes of gynecologic neoplasmsA A Ashour, C F Verschraegen, A P Kudelka, et al.
Cancer Chemotherapy and Pharmacology|November 17, 2001
Maturation of dendritic cells from ovarian cancer patientsE Zavadova, C A Savary, S Templin, et al.
European Journal of Gynaecological Oncology|October 31, 2000
Estrogen replacement therapy and ovarian cancerT Sittisomwong, A Suneja, A P Kudelka, et al.
European Journal of Gynaecological Oncology|January 1, 1997
Prolonged remission of platinum-refractory ovarian cancer with docetaxel: brief report and review of literatureO Balat, A P Kudelka, C L Edwards, et al.
Hematology/Oncology Clinics of North America|March 18, 1999
The role of macrophages in antitumor defense of patients with ovarian cancerE Zavadova, A Loercher, S Verstovsek, et al.
Anticancer Research|March 1, 1991
Specific organ metastases of human melanoma cells injected into the arterial circulation of nude miceC F Verschraegen, B C Giovanella, J T Mendoza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 1998
Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell linesB Melichar, G Ferrandina, C F Verschraegen, et al.
Anti-Cancer Drugs|October 19, 2000
Use of docetaxel (Taxotere) in patients with paclitaxel (Taxol) hypersensitivityC Moon, C F Verschraegen, M Bevers, et al.
Clinical & Experimental Metastasis|February 24, 2001
Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumorsW Hu, P D McCrea, M Deavers, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Anticancer Research|January 1, 1995
Modulation of the response to chemotherapy in a human melanoma clone by the site of growth in the nude mouseC F Verschraegen, J T Mendoza, A J Kozielski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Paraneoplastic syndromes of gynecologic neoplasmsA A Ashour, C F Verschraegen, A P Kudelka, et al.
Cancer Chemotherapy and Pharmacology|November 17, 2001
Maturation of dendritic cells from ovarian cancer patientsE Zavadova, C A Savary, S Templin, et al.
European Journal of Gynaecological Oncology|October 31, 2000
Estrogen replacement therapy and ovarian cancerT Sittisomwong, A Suneja, A P Kudelka, et al.
European Journal of Gynaecological Oncology|January 1, 1997
Prolonged remission of platinum-refractory ovarian cancer with docetaxel: brief report and review of literatureO Balat, A P Kudelka, C L Edwards, et al.
Hematology/Oncology Clinics of North America|March 18, 1999
The role of macrophages in antitumor defense of patients with ovarian cancerE Zavadova, A Loercher, S Verstovsek, et al.
Anticancer Research|March 1, 1991
Specific organ metastases of human melanoma cells injected into the arterial circulation of nude miceC F Verschraegen, B C Giovanella, J T Mendoza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 1998
Growth inhibitory effects of aromatic fatty acids on ovarian tumor cell linesB Melichar, G Ferrandina, C F Verschraegen, et al.
Anti-Cancer Drugs|October 19, 2000
Use of docetaxel (Taxotere) in patients with paclitaxel (Taxol) hypersensitivityC Moon, C F Verschraegen, M Bevers, et al.
Clinical & Experimental Metastasis|February 24, 2001
Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumorsW Hu, P D McCrea, M Deavers, et al.
Pageof 7